<DOC>
	<DOCNO>NCT02120794</DOCNO>
	<brief_summary>The study objective demonstrate home use Threshold Suspend ( TS ) associate glycemic deterioration pediatric patient type 1 diabetes , measure change A1C .</brief_summary>
	<brief_title>Threshold Suspend Pediatrics Home</brief_title>
	<detailed_description>This study longitudinal , multi-center trial aim observe Threshold Suspend ( TS ) feature sensor-augmented insulin pump patient 7-15 year Type 1 diabetes . The study measure change A1C baseline period one year subject wear study pump .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . Subject age 7 15 time screen 2 . Subject diagnose type 1 diabetes mellitus must diagnose least one year prior screen 3 . Subject currently transition pump therapy , without continue glucose monitoring ( CGM ) , 530G insulin pump system . 4 . Subject willing perform great equal 4 finger stick blood glucose measurement daily 5 . Subject willing perform require sensor calibration 6 . Subject willing wear system ( Pump , glucose sensor , meter ) continuously throughout study 7 . Subject willing upload data every 21 day study pump 8 . Subject must Internet access access computer system meet requirement upload pump . This may include use family friend 's computer system Internet access . 9 . Subject use either Humalog Novolog time Screening plan use either insulin throughout study 1 . Subject actively participate investigational study ( drug device ) wherein he/she receive treatment investigational study drug investigational study device . 2 . Women childbearing potential positive pregnancy test screening plan become pregnant course study 3 . Subject treat hyperthyroidism time screen 4 . Subject abnormality ( &gt; 1.8mg/dL ) creatinine time screen visit 5 . Subject abnormality ( reference range ) thyroidstimulating hormone ( TSH ) time screen visit ; If TSH range , Free T3 Free T4 test ; subject may include TSH range long Free T3 Free T4 normal reference range . 6 . Subject take oral , injectable , IV steroid within 8 week time screen visit , plan take oral , injectable , IV steroids course study 7 . Subject currently abuse illicit drug 8 . Subject currently abuse prescription drug 9 . Subject currently abuse alcohol 10 . Subject use pramlintide ( Symlin ) time screen 11 . Subject sickle cell disease , hemoglobinopathy ; receive red blood cell transfusion erythropoietin within 3 month prior time screen 12 . Subject plan receive red blood cell transfusion erythropoietin course study participation 13 . Subject diagnose current eating disorder anorexia bulimia 14 . Subject diagnose chronic kidney disease result chronic anemia 15 . Subject dialysis 16 . Subject already 530G system CGM 8 day .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Threshold Suspend</keyword>
	<keyword>Sensor augment pump</keyword>
</DOC>